FIELD: gynecology. SUBSTANCE: proposed contraceptive agent is the combined estrogen-gestagenic preparation (ethynylestradiol and acetomepregenol) at three-phase dose regime. Agent has acetomepregenol as progestagen at the following ratio of components, mas. p. at the 1-st phase - acetomepregenol 1.33-1.67, ethynylestradiol 1.0-1.33; at the 2-d phase acetomepregenol 1.33-2.0, ethynylestradiol 1.0-1.33; at the 3-d phase acetomepregenol 2.0-4.17, ethynylestradiol 0.67-1.0. EFFECT: enhanced effectiveness of agent. 8 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION SHOWING CONTRACEPTIVE EFFECT | 0 |
|
SU1789216A1 |
CONTRACEPTIVE METHOD AND REMEDY FOR ANIMALS | 1993 |
|
RU2048149C1 |
17α-ACETOXY-3β-BUTANOYLHYDROXY-6-METHYLPREGNA-4,6-DIENE-20-ONE SHOWING GESTAGENIC ACTIVITY | 1996 |
|
RU2099347C1 |
MEDICINAL PREPARATION POSSESSING ANTITUMOR ACTIVITY | 1988 |
|
RU2039560C1 |
UNIVERSAL AGENT FOR INHIBITION OF VERTEBRATE ANIMAL REPRODUCTION | 1996 |
|
RU2101013C1 |
17α-ACETOXY-3β-HEXANOYLOXY-6-METHYLPREGNA-4,6-DIEN-20-ON WITH GESTAGENIC, CONTRACEPTIVE AND ANTITUMOR ACTIVITY, AND THE METHOD OF ITS OBTAINING | 2018 |
|
RU2683953C1 |
COMPOSITION ELICITING CONTRACEPTIVE ACTIVITY | 2002 |
|
RU2238095C2 |
PHARMACEUTICAL COMBINED PREPARATION FOR HORMONAL CONTRACEPTION | 1995 |
|
RU2165258C2 |
METHOD FOR OBTAINING CONTRACEPTIVE PREPARATION FOR ANIMALS | 2003 |
|
RU2268728C2 |
ORAL FORM OF GESTAGEN-CONTAINING COMPOSITION FOR TREATING WOMEN WITH CONDITIONS OF GESTAGEN INSUFFICIENCY AND METHOD FOR PREPARING IT | 2018 |
|
RU2684917C1 |
Authors
Dates
1995-09-10—Published
1987-11-04—Filed